GSK PLC LS-,3125/ GB00BN7SWP63 /
09/05/2024 08:05:54 | Var. -0.050 | Volume | Denaro13:30:30 | Lettera13:30:30 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
20.460EUR | -0.24% | 0 Fatturato: 0.000 |
20.660Quantità in denaro: 1,300 | 20.700Quantità in lettera: 1,300 | 83.29 bill.EUR | - | - |
GlobeNewswire
13:45
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp
13:30
Cosa Resources Announces Summer Exploration Plans for Athabasca Basin Uranium Projects
GlobeNewswire
13:30
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
13:30
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire
13:30
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire
13:30
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
GlobeNewswire
13:30
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
13:30
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
GlobeNewswire
13:30
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
13:30
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
13:30
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024
GlobeNewswire
13:30
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updat...